Main Session
Sep
30
SS 33 - GI 2: Giving radiation a boost in pancreatic cancer and responding to the call for esophageal cancer
289 - Sequential Chemo-immunotherapy as a Novel Bridging Strategy for Non-Complete Responders after Neoadjuvant Chemoradiotherapy in Esophageal Cancer: First Prospective Phase 2 Trial Challenging Immediate
Presenter(s)
Qifeng Wang, MD, PhD - Sichuan Cancer Hospital and Institute, Chengdu, Sichuan